Software facilitates clinical trial development process.

Press Release Summary:

Comprising several web-based modules, IMPACT® helps pharmaceutical companies manage, track, and organize critical data involved in effectively running clinical trial, from planning and monitoring to data collection and reporting. It features MySites online and offline web-based site management and monitoring module that offers 24/7 access from anywhere, allowing work on all aspects of site management including monitoring, milestone planning, issue resolution, and recruitment.

Original Press Release:

Perceptive Informatics Improves the Clinical Development Process with Enhanced CTMS Technology

BOSTON, Aug. 9 / Perceptive Informatics, the technology subsidiary of PAREXEL International Corporation (NASDAQ:PRXL), today announced the release of an enhanced version of its comprehensive clinical trial management system (CTMS) IMPACT® technology with improved site management and monitoring capabilities. With over 25,000 users in 85 countries, Perceptive Informatics' IMPACT software is the world's most widely used CTMS technology.

"As clients face further globalization of clinical trials and require site management and monitoring of increasingly complex studies, they need technology that keeps pace. Perceptive has enhanced its highly flexible CTMS platform to support these vital needs," said Mark A. Goldberg, M.D., President, Clinical Research Services and Perceptive Informatics, PAREXEL International.

Dr. Goldberg added, "At PAREXEL, we have a continued commitment to using innovative technology to better serve clients. PAREXEL's implementation of this next generation of the IMPACT technology throughout our own worldwide clinical research organization will allow us to seamlessly and securely share clinical study data with clients also using the IMPACT platform. This will promote even more efficient and effective management of their programs."

The IMPACT software comprises several web-based modules designed to deliver practical and tangible results, decreasing the time, cost, and risk associated with the development of new products. The software provides planning and tracking support for all aspects of a clinical trial and consolidates information from various collection points into a single source. The IMPACT solution is scalable to support studies of all sizes ranging from large, multi-national studies to single center studies. The most recent version features an online and offline web-based site management and monitoring module, called MySites, which offers 24/7/365 access from anywhere in the world, enabling work on all aspects of site management including monitoring, milestone planning, issue resolution and recruitment.

"More than half of the world's top 20 pharmaceutical companies rely on Perceptive's IMPACT solution to manage, track, and organize the critical data involved in effectively running a clinical trial, from planning and monitoring to data collection and reporting," said Todd A. Joron, Corporate Vice President and General Manager of Perceptive Informatics. "The enhanced IMPACT platform features a number of concrete benefits, including increased cost efficiencies, to help clients continue to improve the speed and effectiveness of their clinical development programs."

About Perceptive Informatics, a PAREXEL Company

PAREXEL's Technology Division, Perceptive Informatics, combines clinical knowledge, quality and regulatory experience with advanced technology to decrease time to market, risk and cost associated with clinical trials. Perceptive's portfolio includes Medical Imaging, Clinical Trial Management Systems (CTMS), Interactive Voice Response Systems (IVRS & IWRS), and Integration Services as well as web-based portal solutions, tracking tools, electronic diaries and investigator database solutions. Perceptive offers medical imaging services to rapidly and objectively assess the safety and efficacy of new drugs, biologics and medical devices in clinical trials. The IMPACT(TM) solution is Perceptive's market-leading CTMS product with 25,000 users worldwide, and Perceptive's INITIATOR(TM) trial management product targets the needs of Phase I units. For more information about Perceptive Informatics, visit

About PAREXEL International

PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 56 locations throughout 43 countries around the world, and has 6,485 employees. For more information about PAREXEL International visit

FCMN Contact:


Jennifer Baird, Director of Public Relations
PAREXEL International
Tel: +781-434-4409

Web site:

All Topics